Hao Cui - Concepedia

Author

Hao Cui

Southern Medical University ORCID

Also Known As

Chen Xiao, H Cui, H. Cui, Haihong Cui, Hao Cui

Publications

564

Citations

H-Index

Concepts

All Affiliations

Southern Medical University Nanfang Hospital University of South China First Affiliated Hospital of University of South China Guangzhou First People's Hospital

About

Hao Cui is an author at Southern Medical University specializing in medicine, radiology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	27
2	Health Sciences	1	1	13
3	Cell Biology	1	1	14
4	Hepatology	1	1	13
5	Immunology	1	1	14

Hao Cui

Publications

485

Citations

H-Index

Page 1

	Year	Citations
Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy Yuyue Zhao, Yuanwei Pan, Ke‐Long Zou, Bioactive Materials	2022	104
Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study Chang Hong, Chengkai Wu, Pengcheng Ma, BMC Gastroenterology	2022	41
Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants Jiaren Wang, Lin Zeng, Chang Hong, Clinical Endocrinology	2023	39
Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies Lin Zeng, Yan Li, Hong Chang, Osteoporosis International	2024	39
A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank Peng‐Cheng Ma, Qimei Li, Ruining Li, Frontiers in Pharmacology	2024	34
Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors Lushan Xiao, Chengyi Hu, Hao Cui, Cancer Medicine	2022	31
Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis Qixuan Xu, Jingwang Gao, Ruiyang Zhao, Pharmacological Research	2024	29
Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study Lushan Xiao, Rui-ning Li, Hao Cui, BMC Cancer	2022	27
TIMER3: an enhanced resource for tumor immune analysis Hao Cui, Guile Zhao, Yiwen Lu, Nucleic Acids Research	2025	24
Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors Lushan Xiao, Qimei Li, Chengyi Hu, Annals of Palliative Medicine	2021	23

Page 1